Asia Proton Therapy Market to See Triple Growth through 2022, Forecasts iGATE Research in Its New Report Recently Added at MarketPublishers.com12 May 2017 • by Natalie Aster
LONDON – Asia captures close to 60% of the world’s population and 50% of the overall burden of cancer.
Asia’s proton therapy market is anticipated to see triple growth through to 2022. The number of proton therapy centers is on a constant rise in the region. Still, players are believed to be deprived of most cancer patients, who can take advantage of proton beam therapy, missing an enormous multibillion-dollar potential marketplace. The number of patients that are being treated with proton radiation is extremely low, while the number of potential candidates for proton beam therapy is huge.
The key factors fuelling the market growth comprise technological advances, surging incidence of cancer as well as huge benefits provided by proton therapy. However, massive investments, operational challenges, the need for more clinical evidence could hinder the market growth.
Japan takes the lead in the regional proton therapy market, with South Korea following after. The Chinese proton therapy market has a huge opportunity for growth due to a large pool of cancer patients. As for India, 2 proton therapy centers are in development and are planned to open during 2018-2019.
Mitsubishi is the dominant player in Japan’s proton therapy market, with other players such as IBA, Sumitomo, Hitachi, amid others, having begun making their presence felt in the marketplace. IBA, for instance, has one operating proton therapy center in China, with additional 4 centers being still development stage.
New insightful research report “Asia Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” elaborated by iGATE Research gives a clear, all-round evaluation of the high-growth, rapidly evolving proton therapy sector in the Asian region.
The study estimates and forecasts the actual and potential proton therapy market, actual and potential patient numbers from 2009 up to 2022. It provides the region’s proton therapy actual and potential market share and candidate share, based on country. The study lists in detail the available proton therapy centers, featuring the start of therapy, number of patients treated, etc.; sheds light on the present-day radiation therapies; takes a shrewd look at the components of a standard proton therapy center. Furthermore, the research study casts light on the market growth driving factors and challenges. The report canvasses the competitive scenario and profiles the 4 leading market participants.
More new comprehensive research reports by the publisher are at hand in the iGATE Research catalogue at MarketPublishers.com.